Pro-Pharmaceuticals, Inc. Selects SAFC(R), a Division of Sigma-Aldrich Corporation, to Submit a Drug Master File

NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a company "Advancing Drugs Through Glycoscience®", today announced a collaboration with SAFC®, the custom manufacturing services division of Sigma-AldrichTM (Nasdaq: SIAL) to submit a Drug Master File (DMF) to the U.S. Food and Drug Administration (FDA) for its lead product candidate, DAVANAT®.

Back to news